JP2023523770A5 - - Google Patents
Info
- Publication number
- JP2023523770A5 JP2023523770A5 JP2022566012A JP2022566012A JP2023523770A5 JP 2023523770 A5 JP2023523770 A5 JP 2023523770A5 JP 2022566012 A JP2022566012 A JP 2022566012A JP 2022566012 A JP2022566012 A JP 2022566012A JP 2023523770 A5 JP2023523770 A5 JP 2023523770A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- alkyl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017679P | 2020-04-30 | 2020-04-30 | |
| US63/017,679 | 2020-04-30 | ||
| PCT/IB2021/053517 WO2021220183A1 (en) | 2020-04-30 | 2021-04-28 | Imidazopyrimidines as modulators of il-17 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023523770A JP2023523770A (ja) | 2023-06-07 |
| JP2023523770A5 true JP2023523770A5 (enExample) | 2024-04-15 |
| JP7661361B2 JP7661361B2 (ja) | 2025-04-14 |
Family
ID=75769661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566012A Active JP7661361B2 (ja) | 2020-04-30 | 2021-04-28 | Ｉｌ－１７のモジュレーターとしてのイミダゾピリミジン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12559496B2 (enExample) |
| EP (1) | EP4143193B1 (enExample) |
| JP (1) | JP7661361B2 (enExample) |
| KR (1) | KR20230018387A (enExample) |
| CN (1) | CN115867348B (enExample) |
| AU (1) | AU2021262588A1 (enExample) |
| BR (1) | BR112022021957A2 (enExample) |
| CA (1) | CA3181793A1 (enExample) |
| IL (1) | IL297734A (enExample) |
| MX (1) | MX2022013650A (enExample) |
| WO (1) | WO2021220183A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023166172A1 (en) | 2022-03-04 | 2023-09-07 | Leo Pharma A/S | Small molecule modulators of il-17 |
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2809660B1 (en) | 2012-02-02 | 2016-01-20 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
| GB201321736D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| ES2702126T3 (es) | 2013-12-10 | 2019-02-27 | Bristol Myers Squibb Co | Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa |
| MA40759A (fr) | 2014-09-26 | 2017-08-01 | Pfizer | Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation |
| US10152431B2 (en) | 2015-03-16 | 2018-12-11 | Honeywell International Inc. | System and method for remote set-up and adjustment of peripherals |
| US10479793B2 (en) * | 2015-11-18 | 2019-11-19 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses |
| GB201709456D0 (en) * | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| US11472794B2 (en) * | 2018-01-15 | 2022-10-18 | UCB Biopharma SRL | Fused imidazole derivatives as IL-17 modulators |
| CN110511213B (zh) | 2018-05-22 | 2021-10-19 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| US11993574B2 (en) | 2018-06-15 | 2024-05-28 | Reata Pharmaceuticals, Inc | Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma |
| EP3820567A1 (en) * | 2018-07-12 | 2021-05-19 | UCB Biopharma SRL | Spirocyclic indane analogues as il-17 modulators |
| US20230167497A1 (en) | 2020-04-30 | 2023-06-01 | Xiaohua Xue | Methods of identifying modulators of the il-17 pathway |
| MX2022013637A (es) | 2020-04-30 | 2022-11-16 | Janssen Pharmaceutica Nv | Nuevos compuestos de triazinoindol. |
| PE20230469A1 (es) | 2020-04-30 | 2023-03-14 | Janssen Pharmaceutica Nv | Imidazopiridazinas como moduladores de il-17 |
-
2021
- 2021-04-28 CN CN202180047235.4A patent/CN115867348B/zh active Active
- 2021-04-28 US US17/997,437 patent/US12559496B2/en active Active
- 2021-04-28 AU AU2021262588A patent/AU2021262588A1/en not_active Abandoned
- 2021-04-28 IL IL297734A patent/IL297734A/en unknown
- 2021-04-28 JP JP2022566012A patent/JP7661361B2/ja active Active
- 2021-04-28 WO PCT/IB2021/053517 patent/WO2021220183A1/en not_active Ceased
- 2021-04-28 CA CA3181793A patent/CA3181793A1/en active Pending
- 2021-04-28 MX MX2022013650A patent/MX2022013650A/es unknown
- 2021-04-28 EP EP21723010.1A patent/EP4143193B1/en active Active
- 2021-04-28 BR BR112022021957A patent/BR112022021957A2/pt not_active Application Discontinuation
- 2021-04-28 KR KR1020227041944A patent/KR20230018387A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023523770A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| JP2023524018A5 (enExample) | ||
| JP2023520925A5 (enExample) | ||
| DE69431056T2 (de) | Substituierte oxazolyl-derivate zur behandlung von entzündungen | |
| JP2024536869A5 (enExample) | ||
| JP2022545633A5 (enExample) | ||
| JP2025504859A5 (enExample) | ||
| JP2024167182A5 (enExample) | ||
| JP2023520924A5 (enExample) | ||
| JP2024001048A5 (enExample) | ||
| JP2024536863A5 (enExample) | ||
| JP2019510787A5 (enExample) | ||
| JPWO2019160057A5 (enExample) | ||
| JPH09505829A (ja) | 炎症および炎症関連障害を処置するための１，４，５−トリフェニルピラゾリル化合物 | |
| JP2024516033A5 (enExample) | ||
| JP2000198773A (ja) | アゾール化合物、その製造法および用途 | |
| JP2024536862A5 (enExample) | ||
| TW201920153A (zh) | 具有環狀構造的化合物 | |
| JP2009537544A5 (enExample) | ||
| JPH11228548A (ja) | アゾール化合物、その製造法および用途 | |
| JPH07502022A (ja) | トリアゾール抗真菌剤 | |
| JP2020520359A5 (enExample) | ||
| JP2019529460A5 (enExample) | ||
| JP2019537624A5 (enExample) |